Medical News

Diabetes patients control blood sugar to avoid microvascular and macrovascular complications. Patients who have concentrations less than 7% of hemoglobin have a very low risk of complications. The blood sugar level is directly related to the concentration of hemoglobin A1c.
A study consisting of 418 patients with two different types of diabetes, and was published in The Lancet. It was conducted by Professor Reinhard G Bretzel of Justus-Liebig-Universität Giessen, Germany. The study was conducted by having 205 individuals injected insulin glargine once per day. While at the same time every day 210 individuals injected insulin lispro three times per day. The conclusion came out to be that a single daily injection of insulin helps as much as controlling diabetes with injections up to three times a day. In addition, insulin users are more satisfied with the insulin glargine than the insulin lispro.

At the end of 44 weeks, there had been a clear decrease in the amounts of hemoglobin A1c. The rate of decrease was of 1.7% for the insulin glargine users and for the insulin lispro group, it was 1.9% decrease in the rate.

Diabetes patients control blood sugar to avoid microvascular and macrovascular complications. Patients who have concentrations less than 7% of hemoglobin have a very low risk of complications. The blood sugar level is directly related to the concentration of hemoglobin A1c.
A study consisting of 418 patients with two different types of diabetes, and was published in The Lancet. It was conducted by Professor Reinhard G Bretzel of Justus-Liebig-Universität Giessen, Germany. The study was conducted by having 205 individuals injected insulin glargine once per day. While at the same time every day 210 individuals injected insulin lispro three times per day. The conclusion came out to be that a single daily injection of insulin helps as much as controlling diabetes with injections up to three times a day. In addition, insulin users are more satisfied with the insulin glargine than the insulin lispro.

At the end of 44 weeks, there had been a clear decrease in the amounts of hemoglobin A1c. The rate of decrease was of 1.7% for the insulin glargine users and for the insulin lispro group, it was 1.9% decrease in the rate.